Literature DB >> 20425478

The healthcare burden imposed by liver disease in aging Baby Boomers.

Gary L Davis1, William L Roberts.   

Abstract

The Baby Boomer generation is composed of 78 million Americans who are just beginning to reach their retirement years. Most Boomers have at least one chronic health problem, and these significantly increase the expense of providing medical care. Liver disease is the 12th most common cause of death in the United States, representing a relatively small portion of overall healthcare costs compared with cardiovascular disease and malignancy. Nonetheless, hepatitis C and fatty liver disease are more common in the Boomers and may play a more dominant role as they age. As a consequence, primary liver cancer is likely to become more prevalent. As with most chronic illnesses, prevention rather than disease management is likely to have the greatest impact. For those already afflicted by chronic liver disease, recognition and treatment can reduce the incidence of late complications, as was clearly demonstrated with chronic hepatitis B and C. Perhaps obesity is the greatest threat to our future health, and fatty liver disease, although likely preventable, will probably become the disease that fills the waiting rooms of future hepatologists.

Entities:  

Mesh:

Year:  2010        PMID: 20425478     DOI: 10.1007/s11894-009-0087-2

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  44 in total

1.  Burden of liver disease in the United States: summary of a workshop.

Authors:  W Ray Kim; Robert S Brown; Norah A Terrault; Hashem El-Serag
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

2.  The effect of obesity on disability vs mortality in older Americans.

Authors:  Soham Al Snih; Kenneth J Ottenbacher; Kyriakos S Markides; Yong-Fang Kuo; Karl Eschbach; James S Goodwin
Journal:  Arch Intern Med       Date:  2007-04-23

3.  Surgical treatment of obesity--weighing the facts.

Authors:  Malcolm K Robinson
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

4.  Insulin resistance. Prosperity's plague.

Authors:  Gary Taubes
Journal:  Science       Date:  2009-07-17       Impact factor: 47.728

5.  The long-term pathological evolution of chronic hepatitis C.

Authors:  M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

6.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Authors:  Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

7.  Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

Authors:  F Degos; C Christidis; N Ganne-Carrie; J P Farmachidi; C Degott; C Guettier; J C Trinchet; M Beaugrand; S Chevret
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

8.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

9.  Post-liver transplant survival in hepatitis C patients is improving over time.

Authors:  Jacqueline G O'Leary; Henry Randall; Nicholas Onaca; Linda Jennings; Göran B Klintmalm; Gary L Davis
Journal:  Liver Transpl       Date:  2009-04       Impact factor: 5.799

10.  Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults.

Authors:  Corinna Koebnick; Darios Getahun; Kristi Reynolds; Karen J Coleman; Amy H Porter; Jean M Lawrence; Mark Punyanitya; Virginia P Quinn; Steven J Jacobsen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-05       Impact factor: 2.839

View more
  12 in total

1.  MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis.

Authors:  Tobias Heye; Schu-Ren Yang; Michael Bock; Sylvia Brost; Kilian Weigand; Thomas Longerich; Hans-Ulrich Kauczor; Waldemar Hosch
Journal:  Eur Radiol       Date:  2012-02-03       Impact factor: 5.315

2.  Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States.

Authors:  Summer S Han; Scott P Kelly; Yuqing Li; Baiyu Yang; Mindie Nguyen; Samuel So; Philip S Rosenberg; Ann W Hsing
Journal:  J Natl Cancer Inst       Date:  2019-06-01       Impact factor: 13.506

3.  Resource utilization and survival among Medicare patients with advanced liver disease.

Authors:  Munkhzul Otgonsuren; Linda Henry; Sharon Hunt; Chapy Venkatesan; Alita Mishra; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2014-08-10       Impact factor: 3.199

Review 4.  Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Authors:  Zobair M Younossi; Linda Henry
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

5.  Consequences of perceived stigma among patients with cirrhosis.

Authors:  Valerie Vaughn-Sandler; Carey Sherman; Andrew Aronsohn; Michael L Volk
Journal:  Dig Dis Sci       Date:  2013-11-19       Impact factor: 3.199

6.  Trends in the prevalence of thrombocytopenia among individuals infected with hepatitis C virus in the United States, 1999-2008.

Authors:  Teresa L Kauf; David R Nelson; Jonathan Schelfhout; Joseph A C Delaney; Peter Feng Wang
Journal:  BMC Res Notes       Date:  2012-03-13

7.  Patients' willingness to accept the risks and benefits of new treatments for chronic hepatitis C virus infection.

Authors:  Teresa L Kauf; Ateesha F Mohamed; A Brett Hauber; Derek Fetzer; Atiya Ahmad
Journal:  Patient       Date:  2012       Impact factor: 3.883

8.  Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis.

Authors:  Mehmet Sayiner; Munkhzul Otgonsuren; Rebecca Cable; Issah Younossi; Mariam Afendy; Pegah Golabi; Linda Henry; Zobair M Younossi
Journal:  J Clin Gastroenterol       Date:  2017-03       Impact factor: 3.062

9.  A qualitative study to explore the role of pharmacists in healthy weight management in adults in Pakistan: current scenario and future perspectives.

Authors:  Muhammad Atif; Sanah Hasan; Irem Mushtaq; Sareema Javaid; Noureena Asghar; Shane Scahill
Journal:  BMC Health Serv Res       Date:  2020-06-15       Impact factor: 2.655

10.  Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States.

Authors:  Pegah Golabi; Munkhzul Otgonsuren; Winnie Suen; Aaron B Koenig; Bashir Noor; Zobair M Younossi
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.